10 Best Low Priced Stocks to Get Rich in 2026
These days, everyone is focusing on finding ways to get rich. The real catch is when this opportunity comes at a low price.
Avalo Therapeutics Inc. (AVTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 3,610,000 | $66,712,800 | 0.97% | |
| 2. | Caligan Partners David Johnson | 3,163,866 | $58,468,244 | +94% | 2.75% |
| 3. | Farallon Capital Thomas Steyer | 2,498,000 | $46,163,040 | +173% | 0.21% |
| 4. | Point72 Asset Management Steve Cohen | 2,387,026 | $44,112,240 | +161% | 0.05% |
| 5. | VenBio Select Advisor Kurt Von Emster | 2,333,333 | $43,119,994 | +66% | 0.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 500 | $6,500.00 | 1,000 | 2024-11-13 | Filing | |
| $12.50 | 500 | $6,249.50 | 500 | 2024-11-12 | Filing | |
| $0.62 | 182,300 | $113,026.00 | 0 | 2023-06-26 | Filing | |
| $0.64 | 1,425,700 | $917,152.81 | 0 | 2023-06-26 | Filing | |
| $4.14 | 2,000 | $8,288.80 | 1,425,700 | 2023-06-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.59 | 2,655 | $52,012.25 | 37,041 | 2026-08-11 | Filing | |
| $20.00 | 679 | $13,580.00 | 51,776 | 2026-08-10 | Filing | |
| $20.00 | 1,000 | $20,000.00 | 51,776 | 2026-07-27 | Filing | |
| $20.00 | 4,654 | $93,080.00 | 51,776 | 2026-06-30 | Filing | |
| $18.00 | 1,450 | $26,100.00 | 51,776 | 2026-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,100,216 | $94,251,992 | 0% | |
| 2. | 4,365,553 | $80,675,418 | 0% | |
| 3. | 3,017,120 | $55,756,378 | 1.34% | |
| 4. | 2,900,000 | $53,592,000 | 2.42% | |
| 5. | 2,889,287 | $53,394,024 | 0% |
News See All
Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)
Avalo Therapeutics, Inc. (NASDAQ:AVTX) is one of the top long-term biotechnology stocks to buy. On October 17, Piper Sandler analyst Yasmeen Rahimi reaffirmed her Buy rating on Avalo Therapeutics Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
Momentum in biotechnology stocks is accelerating after years of underperformance.
Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances
Avalo Therapeutics, Inc. (NASDAQ:AVTX) is among the best growth stocks to invest in for the next 5 years. On Monday, the management of Avalo Therapeutics, Inc.
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
5 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 5 hot healthcare stocks to buy now.
Hedge Fund Resource Center